期刊文献+

二甲双胍抑制Foxp3的表达诱导乳腺癌细胞凋亡 被引量:2

Metformin induced apoptosis in breast cancer cell by decreasing the expression of Foxp3
下载PDF
导出
摘要 目的研究二甲双胍对于人乳腺癌细胞MCF-7增殖与调亡的效应,并探讨Foxp3在其中的作用。方法分别以二甲双胍(5mmol/L、10mmol/L、20mmol/L)干预人乳腺癌细胞MCF-7 48h后,采用MTT法检测细胞增殖抑制率;Hoechst33258染色和流式细胞仪分析细胞凋亡;实时(real-time)PCR检测Foxp3和caspase-3mRNA表达水平;Western blot法检测Foxp3蛋白的表达。结果与对照组(未经二甲双胍处理)相比,二甲双胍作用MCF-7细胞48h后,对细胞增殖有明显抑制作用(P<0.05);并可明显诱导MCF-7细胞凋亡,早期凋亡率分别为3.76%、8.96%和18.67%;经二甲双胍处理后,MCF-7细胞中caspase-3mRNA表达水平显著上调(P<0.05),而Foxp3mRNA和Foxp3蛋白表达水平降低(P<0.05)。结论二甲双胍有抑制MCF-7增殖并诱导其凋亡的作用,其机制可能与Foxp3表达下调有关。 Objective To research the effects of metformin on proliferation and apoptosis in human breast cancer MCF-7cells and investigate the role of Foxp3 in the effect.Methods The inhibit rate of MCF-7cells was measured by MTT assay after 48 h metformin treatment(5mmol/L、10mmol/L、20mmol/L).Metformin-induced cell apoptosis was measured by Hoechst 33258 staining and flow cytometry.The expression levels of Foxp3 and caspase-3mRNA were detected by real-time PCR.Expression of Foxp3 protein was detected by Western blot.Results Metformin markedly inhibited proliferation of MCF-7(P〈0.05)compared with control group.And the early apoptotic rates increased to 3.76%,8.96%,and 18.67% with 5mmol/L、10mmol/L、20mmol/L metformin treatment,respectively.Metformin increased caspase-3mRNA expression levels,and decreased the expression levels of Foxp3 mRNA and protein expression levels(P〈0.05,vs.control).Conclusion Metformin could inhibit the proliferation and induce apoptosis of MCF-7,and its mechanism maybe related to down-regulated expression of Foxp3.
出处 《重庆医学》 CAS CSCD 北大核心 2014年第28期3749-3752,共4页 Chongqing medicine
基金 国家自然科学基金资助项目(81260343) 广西教育厅科研基金资助项目(2013YB159)
关键词 二甲双胍 乳腺肿瘤 细胞凋亡 FOXP3 metformin breast neoplasms apoptosis Foxp3
  • 相关文献

参考文献20

  • 1Baur DM, Klolschc J, Hanmvik OP, et al. Type 2 diabetes mellitus and medications for type 2 diabetes mellltus are associaled with risk for and mortalily from cancer in a German primary cm'v cohort[J]. Metabolism, 2011, 60 (10):1363 -1371.
  • 2Jiralerspong S, Palta SL, Giordano SH, et al. Metformin and pathologic complete responses to neoadjuvant chemo therapy in diabetic patients with breast cancer[J]. J Clin Oncol,2009,27(20) :3297 -3302.
  • 3Hirsch HA, Iliopoulos D, Tsichlis PN, et al. Metformin selectively targets cancer stem ceils, and acts togetherwith chemotherapy to block tumor growth and prolong remission[J]. Cancer Res, 2009,69 (19) : 7507-7511.
  • 4Sanchez-Alvarez R, Martinez-Outschoorn UE, Lamb R, et al. Mitochondrial dysfunction in breast cancer cells pre- vents tumor growth:understanding chemoprevention with metformin[J]. Cell Cycle,2013,12(1) : 172-182.
  • 5Hinz S, Pagerols-Raluy L, Oberg H, et al. Foxp3 expres- sion in pancreatic carcinoma cells as a novel mechanism of immune evasion in cancerFJ]. Cancer Res, 2007,67 (17) : 8344-8350.
  • 6Katoh H,Zheng P, Liu Y. Signalling through Foxp3 as an X-linked tumor suppressor[J]. Int J Biochem Cell Biol, 2010,42(11) :1784-1787.
  • 7Kim M, Grimmig T, Grimm M, et al. Expression of Foxp3 in eolorectal cancer but not in Treg cells correlates with disease progression in patients with colorectal cancer[J]. PLoS One,2013,8(1) :e53630.
  • 8Redpath M, Xu B, van Kempen LC, et al. The dual role of the X-linked FoxP3 gene in human caneers[J]. Mol On- col,2011,5(2) : 156-163.
  • 9Karanikas V, Speletas M, Zamanakou MA, et al. Foxp3 expression in human cancer cells[J]. J Transl Med, 2008, 6,19.
  • 10郑龙轶,邹大进.二甲双胍对人肝细胞癌SMMC7721增殖的抑制作用[J].第二军医大学学报,2010,31(11):1261-1263. 被引量:6

二级参考文献9

  • 1Zhou G,Myers R,Li Y,Chen Y,Shen X,Judy F M,et al. Role of AMP activated protein kinase in mechanism of metformin action[J]. J Clin Invest, 2001,108 : 1167-1174.
  • 2Motoshima H,Goldstein B J,Igata M,Araki E. AMPK and cell proliferation--AMPK as a therapeutic target for atherosclerosis and cancer[J].J Physiol,2006,574(Pt 1):63- 71.
  • 3Zakikhani M, Dowling R, Fantus I G, Sonenberg N, Pollak M. Metformin is an AMP kinase dependent growth inhibitor for breast cancer cells[J]. Cancer Res, 2006,66 : 10269-10273.
  • 4Ben S, I, Le Marchand Brustel Y, Tanti J F, Bost F. Metformin in cancer therapy: a new perspective for an old antidiabetic drug [J]? Mol Cancer Ther,2010,9 : 1092-1099.
  • 5Evans J M,Donnelly L A,Emslie-Smith A M,Alessi D R,Morris A D. Metformin and reduced risk of cancer in diabetic patients[J]. BMJ, 2005,330 : 1304-1305.
  • 6Bowker S L, Majumdar S R, Veugelers P, Johnson J A. Increased cancer related mortality for patients with type 2 diabetes who use sulfonylureas or insulin: response to Farooki and Schneider[J].Diabetes Care, 2006,29 : 1990 -1991.
  • 7Donadon V,Balbi M,Mas M D,Casarin P,Zanette G. Metformin and reduced risk of hepatocellular carcinoma in diabetic pa tients with chronic liver disease[J]. Liver Int,2010,30:750 -758.
  • 8Davila J A,Morgan R O,Shaib Y,McGlynn K. A,EbSerag H B. Diabetes increases the risk of hepatocellular carcinoma in the U nited States: a population based case control study[J].Gut 2005,54:533-539.
  • 9Fabregat I, Roncero C, Fernandez M. Survival and apoptosis: a dysregulated balance in liver cancer[J].Liver Int, 2007,27:155 162.

共引文献5

同被引文献9

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部